mayo clinic glp-1 supplement GLP1 and GIP Receptor Agonists: Effects on the Gastrointestinal Tract and Management Strategies for Primary Care Physicians GLP-1 Medications for Weight Loss

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved these agents for glycaemic control in type 2 diabetes and, in specific formulations and doses (semaglutide as Wegovy and liraglutide as Saxenda), for weight management in adults with obesity or overweight with weight-related comorbidities

A CT scan can also identify fistula, peritonitis, and obstructions

Nausea, constipation and tiredness are among the most common side effects, especially early on

Ozempic is part of a class of diabetes and obesity drugs that mimic the GLP-1 hormone the body naturally produces after eating, suppressing appetite and stimulating weight loss

Davies MJ, van der Meer P, Verma S, Patel S, Chinnakondepalli KM, Borlaug BA, et al